Generic drug maker Sun Pharma has succeeded in invalidating Otsuka Pharmaceutical’s patent for an injectable, controlled release form of the Japanese drug maker’s top-selling antipsychotic Abilify.
Ahead of an eight-week trial in an investor class action in July, ratings agency S&P has lost its bid to throw out the entirety of the expert evidence in the case.
The developer of a suite of Holiday Inn Express hotels has succeeded in its appeal of a ruling that laid bare privileged material connected to its lawyers’ bills.
The High Court has overturned a controversial decision that put a judge on the hook for a man’s false imprisonment, finding that all judges are immune from civil suits for acts done in the performance of their judicial duties.
A class action against BHP can include in the group member definition investors who bought shares on secondary platforms, but the change can’t apply retroactively.
A trans woman who won her discrimination case against the Giggle for Girls app and its CEO Sal Grover has launched a cross-appeal against the landmark decision.
BESIX Watpac and Frasers Property are fighting claims they are liable for defects in two residential complexes in the Sydney suburb of Chippendale, including the $2 billion One Central Park towers.
Lendlease has abandoned its bid to purchase a parcel of land owned by one of Australia’s oldest families for well below market value as part of its project to develop 6,700 homes in Campbelltown, Sydney.
A class action against Exactech over allegedly faulty joint implants has been stayed pending its US-based parent company’s bankruptcy proceedings.
A judge has rejected HSU secretary Diana Asmar’s argument that a case against her over an alleged $2.7 million false invoicing scheme should be stayed because criminal charges were “on the cards”.